Achieving a Sustainable Biosimilars Market: The Role of All Stakeholders

The biosimilars market has significantly grown and matured over the past decade. Biosimilars are projected to save more than $180B in healthcare costs in the US from 2023 to 2027, and yet the future of biosimilars may be threatened due to existing market dynamics. In this session, we will assess the current state of biosimilar sustainability, identify key barriers that exist to maintaining a viable future, and discuss potential strategies to thwart these threats to the future of biosimilars.

It is critical that all stakeholders collectively ensure that the viability of the biosimilars market is protected to continue to deliver on its promise of savings.